<DOC>
	<DOCNO>NCT02572674</DOCNO>
	<brief_summary>Study 400 patient bipolar disorder I II , relapse risk factor . The principal objective research test predictive value core vulnerability dimension affective instability emotional reactivity , measure validated questionnaire ( AIM ALS ) recurrence affective major episode ( depressed , hypomanic manic ) 24 month prospective follow-up . In addition , several argument suggest inter-individual variability risk relapse influence genetic factor . In particular , implication factor demonstrate rapid cycling antidepressant induce mania . However , never test cohort follow prospectively . Finally , existence neuropsychological deficit bipolar disorder well documented role risk relapse suspect . Yet nature deficit , origin evolutionary course remain poorly investigate . In summary , secondary objective research study influence clinical , neuropsychological genetic factor risk relapse . • Scientific rationale The dimension affective instability emotional reactivity , consider core psychological temperamental vulnerability dimension bipolar disorder . Differences level instability reactivity may account inter-individual variability observe bipolar disorder term risk relapse . These dimension measure use validate questionnaire ( Affective Instability Measure ( AIM ) Affective Lability Scale ( ALS ) ) . Relapsing defined occurrence depressive episode , hypomanic , manic mixed episode ( DSMIV criterion ) . Other factor may influence risk relapse suggest literature formally test prospective study : 1. cognitive deficit : existence neuropsychological deficit bipolar disorder well documented role risk relapse suspect . Yet nature deficit , origin course remain poorly investigate . Indeed , appear relate neurotoxicity episode , related vulnerability bipolar disorder 2 . The involvement genetic vulnerability factor bipolar disorder widely demonstrate . Several argument suggest implication genetic factor risk relapse . This case outcome pattern rapid cycle antidepressant induce mania . Again , never test cohort follow prospectively . 3 . The role certain inflammatory infectious factor etiology bipolar disorder suggest clear whether biomarkers `` state '' `` trait '' . Thus , role neurotoxic inflammatory infectious factor relapse mood never test prospective follow study . - Main objective project To determine score AIM ALS , assess baseline euthymic bipolar patient associate relapse patient 2 year follow-up period . - Secondary objective project Determine neuropsychological performance T0 , measure euthymic patient predict relapse 2 year follow-up period . Determine whether neuropsychological deficit observe euthymic bipolar patient contribute functional impairment worsen time . DNA collection test involvement candidate gene Serum collection study biological infectious biomarkers • Methodology Prospective follow study . Multicenter .</brief_summary>
	<brief_title>Study Predictor Mood Relapse Bipolar Disorders</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<criteria>Bipolar disorder I II French language Aging 18 year 55 year Young Mania Rating Scale ( YMRS ) &lt; 12 Montgomery Asberg Depression Rating Scale ( MDRS ) &lt; 10 Rapid cycling Undefined number major relapse Drug alcohol abuse within 6 month Electroconvulsive therapy ( ECT ) within 12 month Epilepsy , traumatism cranial neurological disease Daltonism visual trouble</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Bipolar disorder</keyword>
	<keyword>relapse risk factor</keyword>
	<keyword>prospective follow</keyword>
</DOC>